Bea Herbeck Belnap1, Herbert C Schulberg2, Fanyin He3, Sati Mazumdar3, Charles F Reynolds4, Bruce L Rollman5. 1. Division of General Internal Medicine, Center for Research on Health Care, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States. Electronic address: belnapbh@upmc.edu. 2. Department of Psychiatry, Weill Cornell Medical College, White Plains, NY, United States. 3. Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, United States. 4. Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States. 5. Division of General Internal Medicine, Center for Research on Health Care, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Abstract
OBJECTIVE: To describe an electronic, telephone-delivered, suicide risk management protocol (SRMP) that is designed to guide research staff and safely triage study participants who are at risk for self-harm. METHODS: We tested the SRMP in the context of the NIH-funded randomized clinical trial "Bypassing the Blues" in which 302 patients who had undergone coronary artery bypass graft surgery (CABG) were screened for depression and assessed by telephone 2-weeks following hospital discharge and at 2-, 4-, and 8-month follow-up. We programmed the SRMP to assign different risk levels based on patients' answers from none to imminent with action items for research staff keyed to each of them. We describe frequency of suicidal thinking, SRMP use, and completion of specific steps in the SRMP management process over the 8-month follow-up period. RESULTS:Suicidal ideation was expressed by 74 (25%) of the 302 study participants in 139 (13%) of the 1069 blinded telephone assessments performed by research staff. The SRMP was launched in 103 (10%) of assessments, and the suicidal risk level was classified as moderate or high in 10 (1%) of these assessments, thereby necessitating an immediate evaluation by a study psychiatrist. However, no hospitalizations, emergency room visits, or deaths ascribed to suicidal ideation were discovered during the study period. CONCLUSION: The SRMP was successful in systematically and safely guiding research staff lacking specialty mental health training through the standardized risk assessment and triaging research participants at risk for self-harm. TRIAL REGISTRATION: Clinicaltrials.gov Identifier: NCT00091962 (http://clinicaltrials.gov/ct2/show/NCT00091962?term=rollman+cabg&rank=1). Published by Elsevier Inc.
RCT Entities:
OBJECTIVE: To describe an electronic, telephone-delivered, suicide risk management protocol (SRMP) that is designed to guide research staff and safely triage study participants who are at risk for self-harm. METHODS: We tested the SRMP in the context of the NIH-funded randomized clinical trial "Bypassing the Blues" in which 302 patients who had undergone coronary artery bypass graft surgery (CABG) were screened for depression and assessed by telephone 2-weeks following hospital discharge and at 2-, 4-, and 8-month follow-up. We programmed the SRMP to assign different risk levels based on patients' answers from none to imminent with action items for research staff keyed to each of them. We describe frequency of suicidal thinking, SRMP use, and completion of specific steps in the SRMP management process over the 8-month follow-up period. RESULTS: Suicidal ideation was expressed by 74 (25%) of the 302 study participants in 139 (13%) of the 1069 blinded telephone assessments performed by research staff. The SRMP was launched in 103 (10%) of assessments, and the suicidal risk level was classified as moderate or high in 10 (1%) of these assessments, thereby necessitating an immediate evaluation by a study psychiatrist. However, no hospitalizations, emergency room visits, or deaths ascribed to suicidal ideation were discovered during the study period. CONCLUSION: The SRMP was successful in systematically and safely guiding research staff lacking specialty mental health training through the standardized risk assessment and triaging research participants at risk for self-harm. TRIAL REGISTRATION: Clinicaltrials.gov Identifier: NCT00091962 (http://clinicaltrials.gov/ct2/show/NCT00091962?term=rollman+cabg&rank=1). Published by Elsevier Inc.
Authors: Kenneth E Freedland; Judith A Skala; Robert M Carney; James M Raczynski; C Barr Taylor; Carlos F Mendes de Leon; Gail Ironson; Marston E Youngblood; K Ranga Rama Krishnan; Richard C Veith Journal: Psychosom Med Date: 2002 Nov-Dec Impact factor: 4.312
Authors: Janine Archer; Peter Bower; Simon Gilbody; Karina Lovell; David Richards; Linda Gask; Chris Dickens; Peter Coventry Journal: Cochrane Database Syst Rev Date: 2012-10-17
Authors: Martha L Bruce; Thomas R Ten Have; Charles F Reynolds; Ira I Katz; Herbert C Schulberg; Benoit H Mulsant; Gregory K Brown; Gail J McAvay; Jane L Pearson; George S Alexopoulos Journal: JAMA Date: 2004-03-03 Impact factor: 56.272
Authors: George S Alexopoulos; Charles F Reynolds; Martha L Bruce; Ira R Katz; Patrick J Raue; Benoit H Mulsant; David W Oslin; Thomas Ten Have Journal: Am J Psychiatry Date: 2009-06-15 Impact factor: 18.112
Authors: Bea Herbeck Belnap; Amy Anderson; Kaleab Z Abebe; Ravi Ramani; Matthew F Muldoon; Jordan F Karp; Bruce L Rollman Journal: Psychosom Med Date: 2019 Jul/Aug Impact factor: 4.312
Authors: Bruce L Rollman; Bea Herbeck Belnap; Sati Mazumdar; Kaleab Z Abebe; Jordan F Karp; Eric J Lenze; Herbert C Schulberg Journal: J Gen Intern Med Date: 2016-10-06 Impact factor: 5.128
Authors: Danielle R Busby; Cheryl A King; David Brent; Jaqueline Grupp-Phelan; Madelyn Gould; Kent Page; Theron Charles Casper Journal: Suicide Life Threat Behav Date: 2019-05-31
Authors: Myrthe L Tielman; Mark A Neerincx; Claudia Pagliari; Albert Rizzo; Willem-Paul Brinkman Journal: BMC Med Inform Decis Mak Date: 2019-03-18 Impact factor: 2.796
Authors: Bruce L Rollman; Bea Herbeck Belnap; Kaleab Z Abebe; Michael B Spring; Armando J Rotondi; Scott D Rothenberger; Jordan F Karp Journal: JAMA Psychiatry Date: 2018-01-01 Impact factor: 21.596
Authors: A Rodríguez-Quiroga; I Flamarique; J Castro-Fornieles; K Lievesley; J K Buitelaar; D Coghill; C M Díaz-Caneja; R W Dittmann; A Gupta; P J Hoekstra; L Kehrmann; C Llorente; D Purper-Ouakil; U M E Schulze; A Zuddas; R Sala; J Singh; F Fiori; C Arango; Paramala Santosh Journal: Eur Child Adolesc Psychiatry Date: 2019-05-03 Impact factor: 4.785